세포해리 시장 : 제품 유형, 조직 및 최종 사용자별 - 세계 예측(2025-2030년)

The Cell Dissociation Market was valued at USD 759.32 million in 2023, expected to reach USD 878.60 million in 2024, and is projected to grow at a CAGR of 16.91%, to USD 2,267.64 million by 2030.

Cell dissociation refers to the process of releasing cells from tissues or cultures, typically achieved through enzymatic, chemical, or mechanical methods. This procedure is crucial for various applications, including cell preparation for assays, single-cell RNA sequencing, stem cell research, and therapeutic developments. The necessity of cell dissociation lies in its role in enabling researchers and clinicians to study cellular behaviors and functions in isolated environments, which significantly enhances the understanding of cellular biology and improves the accuracy of experimental outcomes. The end-use scope spans academic research, pharmaceutical and biotechnology industries, with expanding use in regenerative medicine and cancer research being particularly notable.

The market for cell dissociation is propelled by several growth factors, including advancements in biotechnology, the increasing focus on precision medicine, and the rising prevalence of chronic diseases that necessitate advanced therapeutic interventions. Emerging opportunities exist in the development of non-enzymatic dissociation methods that are gentler on cells and the integration of automated processes to increase efficiency and reproducibility. Key recommendations to exploit these opportunities include investment in R&D for innovative dissociation technologies and strategic partnerships with institutions focusing on cutting-edge cell biology research.

However, the market faces limitations such as high costs associated with advanced dissociation technologies, regulatory challenges, and potential cell damage caused by certain dissociation techniques that can affect cell viability and functionality. As companies strive to overcome these hurdles, emphasis on research to improve cell viability post-dissociation and the refinement of techniques to minimize cell stress are potential areas of innovation.

The cell dissociation market is dynamic, characterized by rapid technological advancements and a growing emphasis on sustainability and ethical considerations in research practices. Companies that align their strategies to address these areas while navigating regulatory landscapes and focusing on cost-effective solutions stand to gain a competitive edge in this evolving market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Dissociation Market

The Cell Dissociation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of cell based research activities across pharmaceutical and biopharmaceutical companies
  • Rising incidence and prevalence of chronic and infectious diseases
  • Availability of government funding for stem-cell research activities
• Market Restraints
  • High cost of tissue and cell based procedures
• Market Opportunities
  • Ongoing introduction of advanced cell dissociation products
  • Rising regulatory approvals for the cell dissociation developments
• Market Challenges
  • Limited infrastructure for the cell-based research in underdeveloped countries

Porter's Five Forces: A Strategic Tool for Navigating the Cell Dissociation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Dissociation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Dissociation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Dissociation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Dissociation Market

A detailed market share analysis in the Cell Dissociation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Dissociation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Dissociation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Dissociation Market

A strategic analysis of the Cell Dissociation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Dissociation Market, highlighting leading vendors and their innovative profiles. These include Abeomics Inc., AcceGen, ACROBiosystems Group, ALSTEM, AMS Biotechnology, Becton, Dickinson and Company, Bio-Techne Corporation, Biogenuix Medsystems Pvt. Ltd., Capricorn Scientific, Captivate Bio, LLC, Cell Signaling Technology, Inc., Cellseco Ltd., Cellsystems Gmbh, Celprogen Corporation, Central Drug House. (P) Ltd., Corning Inc., Creative Bioarray, Cytori Therapeutics Inc., Diagnocine, F. Hoffmann-La Roche Ltd., FlowMetric, Inc., Gemini BioProducts LLC, Genaxxon bioscience GmbH, Genlantis Inc., Genomics, Inc., HiMedia Laboratories Private Limited, Innovative Cell Technologies, Inc., Krackeler Scientific, Inc., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, MP Biomedicals, LLC, Nacalai Tesque, Inc., Neuromics, Nordmark Pharma GmbH, PAN-Biotech GmbH, PELOBIOTECH GmbH, PromoCell GmbH, Protein Ark Ltd. by CalibreScientific, REPROCELL Inc., RWD Life Science Co., Ltd., Sartorius AG, ScienCell Research Laboratories, Inc., Singleron Biotechnologies GmbH, STEMCELL Group, Stemmera Inc., Tebubio, Thermo Fisher Scientific Inc., VitaCyte, LLC, VWR International, LLC, and Worthington Biochemical Corporation.

Market Segmentation & Coverage

This research report categorizes the Cell Dissociation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Enzymatic Dissociation Products, Instruments & Accessories, and Non-Enzymatic Dissociation Products. The Enzymatic Dissociation Products is further studied across Collagenase, DNase, Elastase, Hyaluronidase, Papain, and Trypsin.
• Based on Type, market is studied across Cell Detachment and Tissue Dissociation.
• Based on Tissue, market is studied across Connective Tissues, Epithelial Tissues, and Skeletal & Muscles Tissues.
• Based on End-User, market is studied across Pharmaceutical & Biotechnology Companies and Research & Academics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of cell based research activities across pharmaceutical and biopharmaceutical companies
    • 5.1.1.2. Rising incidence and prevalence of chronic and infectious diseases
    • 5.1.1.3. Availability of government funding for stem-cell research activities
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of tissue and cell based procedures
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing introduction of advanced cell dissociation products
    • 5.1.3.2. Rising regulatory approvals for the cell dissociation developments
  • 5.1.4. Challenges
    • 5.1.4.1. Limited infrastructure for the cell-based research in underdeveloped countries
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cell Dissociation Market, by Product

• 6.1. Introduction
• 6.2. Enzymatic Dissociation Products
  • 6.2.1. Collagenase
  • 6.2.2. DNase
  • 6.2.3. Elastase
  • 6.2.4. Hyaluronidase
  • 6.2.5. Papain
  • 6.2.6. Trypsin
• 6.3. Instruments & Accessories
• 6.4. Non-Enzymatic Dissociation Products

7. Cell Dissociation Market, by Type

• 7.1. Introduction
• 7.2. Cell Detachment
• 7.3. Tissue Dissociation

8. Cell Dissociation Market, by Tissue

• 8.1. Introduction
• 8.2. Connective Tissues
• 8.3. Epithelial Tissues
• 8.4. Skeletal & Muscles Tissues

9. Cell Dissociation Market, by End-User

• 9.1. Introduction
• 9.2. Pharmaceutical & Biotechnology Companies
• 9.3. Research & Academics

10. Americas Cell Dissociation Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Cell Dissociation Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Cell Dissociation Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Agilent Announces Acquisition of Company Behind Electron Capture Dissociation Technology
  • 13.3.2. S2 Genomics Announces Distribution Agreement with Techtum Lab AB to Serve Scandinavia
  • 13.3.3. Applied Cells Enters into a Supply Agreement with STEMCELL Technologies on Reagent Kits for Use in a Next-Generation Solution for Cell Separation
  • 13.3.4. LevitasBio Unveils LeviPrep and LeviSelect Product Lines
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abeomics Inc.
• 2. AcceGen
• 3. ACROBiosystems Group
• 4. ALSTEM
• 5. AMS Biotechnology
• 6. Becton, Dickinson and Company
• 7. Bio-Techne Corporation
• 8. Biogenuix Medsystems Pvt. Ltd.
• 9. Capricorn Scientific
• 10. Captivate Bio, LLC
• 11. Cell Signaling Technology, Inc.
• 12. Cellseco Ltd.
• 13. Cellsystems Gmbh
• 14. Celprogen Corporation
• 15. Central Drug House. (P) Ltd.
• 16. Corning Inc.
• 17. Creative Bioarray
• 18. Cytori Therapeutics Inc.
• 19. Diagnocine
• 20. F. Hoffmann-La Roche Ltd.
• 21. FlowMetric, Inc.
• 22. Gemini BioProducts LLC
• 23. Genaxxon bioscience GmbH
• 24. Genlantis Inc.
• 25. Genomics, Inc.
• 26. HiMedia Laboratories Private Limited
• 27. Innovative Cell Technologies, Inc.
• 28. Krackeler Scientific, Inc.
• 29. Merck KGaA
• 30. Miltenyi Biotec B.V. & Co. KG
• 31. MP Biomedicals, LLC
• 32. Nacalai Tesque, Inc.
• 33. Neuromics
• 34. Nordmark Pharma GmbH
• 35. PAN-Biotech GmbH
• 36. PELOBIOTECH GmbH
• 37. PromoCell GmbH
• 38. Protein Ark Ltd. by CalibreScientific
• 39. REPROCELL Inc.
• 40. RWD Life Science Co., Ltd.
• 41. Sartorius AG
• 42. ScienCell Research Laboratories, Inc.
• 43. Singleron Biotechnologies GmbH
• 44. STEMCELL Group
• 45. Stemmera Inc.
• 46. Tebubio
• 47. Thermo Fisher Scientific Inc.
• 48. VitaCyte, LLC
• 49. VWR International, LLC
• 50. Worthington Biochemical Corporation